Alliance Pharma Share News (APH)

Alliance Pharma Information

Buy APH Shares
Add APH to Watchlist
Add APH to Alert

Share Price Information for Alliance Pharma (APH)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 33.10

Bid: 32.95

Ask: 33.85

Change: 0.00 (0.00%)

Spread: 0.90 (2.731%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 33.10

Last checked at -

IN BRIEF: Alliance Pharma buys ScarAway brand from Perrigo

Fri, 25th Mar 2022 12:53

Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Says it acquires silicone-based scar treatment brand ScarAway from Perrigo Co PLC. Alliance Pharma also buys the rights to sell its scar treatment brand brand Kelo-cote in the US. Alliance Pharma pays USD19.4 million in cash from existing financial resources to Dublin, Ireland-based Perrigo for both assets.

Current stock price: 114.80 pence, up 2.5% on Friday

12-month change: up 30%

By Tom Budszus; tombudszus@alliancenews.com

More News

17 Sep 2019 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 18 September KingfisherHalf Year ResultsAccesso TechnologyHalf Year Year Year

10 Jul 2019 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 11 July Kenmare ResourcesHalf Year ProductionMcBrideTrading GroupFull

1 Jul 2019 15:35

Alliance Pharma Founder & Former Chief Executive John Dawson Departs

(Alliance News) - Alliance Pharma PLC said on Monday founder & former chief executive John Dawson decided to step down from the board.Dawson, who was a non-executive director at the on

16 May 2019 17:55

UK Shareholder Meetings Calendar - Next 7 Days

Friday 17 MayRestaurant GroupBank of Georgia GroupCentaur MediaCairn Continental 20

10 Apr 2019 16:05

Alliance Pharma's 'Xonvea' gets approval in Ireland

(Sharecast News) - Alliance Pharma announced on Wednesday that 'Xonvea' has gained marketing approval in the Republic of Ireland from the country's medicines regulator, the Health Products Regulatory Authority, for the treatment of nausea and vomiting of pregnancy where conservative management has failed.

10 Apr 2019 12:27

Alliance Pharma Gets Approval For Anti-Nausea Drug Xonvea In Ireland

LONDON (Alliance News) - Alliance Pharma PLC on Wednesday said its Xonvea drug has been approved in Ireland to treat nausea and vomiting of pregnancy.The Irish marketing approval is first

26 Mar 2019 11:33

Alliance Pharma Raises Annual Dividend Amid Strong Revenue Growth

LONDON (Alliance News) - Alliance Pharma on Tuesday raised its dividend for 2018 amid a strong revenue performance, though profit fell due to impairments.The pharmaceutical retailer said to

19 Mar 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 20 March KingfisherFull Year ResultsCentaur MediaFull Year GroupHalf

21 Jan 2019 12:42

Alliance Pharma's revenues climb as 'star' products shine

(Sharecast News) - Alliance Pharma on Monday reported a jump in revenue after a strong performance from its 'star' products and newly acquired Nizoral brand.

14 Jan 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 15 January Boohoo GroupTrading Statement Gym GroupTrading Workshop Year Year

2 Oct 2018 09:56

Alliance Pharma launches Xonvea in the UK

(Sharecast News) - Alliance Pharma launched its prescription product for the treatment of nausea and vomiting of pregnancy across the UK on Tuesday.

1 Oct 2018 13:02

Strategic Equity Capital Underperforms Against Benchmark In Year

LONDON (Alliance News) - Strategic Equity Capital PLC said on Monday it underperformed against its benchmark for its recently ended financial year, due to an undervalued portfolio.The said

19 Sep 2018 10:00

Alliance Pharma Hikes Interim Payout As Underlying Profit, Sales Rise

LONDON (Alliance News) - Specialty pharmaceuticals firm Alliance Pharma PLC hiked its dividend Wednesday after underlying interim profit improved on the back of rising revenue, despite reported on

19 Sep 2018 09:28

Alliance Pharma overseas transformation continues

(Sharecast News) - As Alliance Pharma's overseas transformation continued throughout the first half of its trading year, the AIM-listed group managed to record some growth in both revenues and profits.

12 Sep 2018 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 13 September GVC HoldingsHalf Year ResultsWM Morrison SupermarketsHalf Year Year

Latest Share Chat

Alliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Alliance Pharma buys ScarAway brand from Perrigo

Login to your account

Quickpicks are a member only feature

Login to your account